| ★ |  Multidisciplinary diagnosis and team treatment in Idiopathic Inflammatory Myopathies | | 64 | — | |
| 12 |  Hydroxychloroquine in connective tissue diseases: benefits and controversial aspects | | 1.8K | — | 89 |
| 13 |  IgG4-related disease (IgG4-RD): update on diagnosis and treatments in 2025 | | 1.3K | — | 89 |
| 8 |  ERN ReCONNET: the New 2026 Webinar Series | | 630 | — | 89 |
| 3 |  Recent advances in the treatment of inflammatory myopathies | | 618 | — | 92 |
| 18 |  Steroids in Relapsing Polychondritis | | 474 | — | 88 |
| 10 |  Quality of life in Relapsing Polychondritis (RP) | | 412 | — | 89 |
| 11 |  Why morning joint stiffness and swelling in rheumatic diseases? | | 398 | — | 89 |
| 15 |  ERN ReCONNET video to launch the RARE DISEASES AWARENESS MONTH 2024! | | 360 | — | 89 |
| 19 |  How to explain the antiphospholipid profile to my patients? | | 300 | — | 88 |
| 4 |  Autoantibodies and clinical phenotypes in Idiopathic Inflammatory Myopathies (IIMs) | | 286 | — | 90 |
| 7 |  Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025? | | 285 | — | 89 |
| 17 |  Pulmonary Function Tests: A Practical Guide for Rheumatologists | | 253 | — | 88 |
| 1 |  Exercise in adult idiopathic inflammatory myopathies (IIMs) | | 188 | — | 93 |
| 6 |  Imaging in Relapsing Polychondritis (RP) | | 171 | — | 90 |
| 20 |  Everything you always wanted to know about Ehlers-Danlos Syndromes (EDS) – Part two | | 151 | — | 88 |
| 16 |  Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering | | 137 | — | 88 |
| 9 |  Osteoporosis in rare and complex connective tissue diseases | | 96 | — | 89 |
| 2 |  ERN ReCONNET ePAG Olga Drápalová: A message for the World Myositis Day, Sept. 21st | | 86 | — | 92 |
| 14 |  3rd ERN ReCONNET Sharing Good Practice 2025 Event | | 84 | — | 89 |
| 5 |  Genetic Testing in the Era of NGS: Lessons from the Hereditary Connective Tissue Disorders | | 35 | — | 90 |